Clinical Trial Update: Aflibercept and Bevacizumab for Diabetic Maculopathies [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial at Al-Mustansiriyah University is recruiting to evaluate aflibercept and bevacizumab for diabetic macular edema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Avastin (bevacizumab)
• EYLEA (Aflibercept)

Snippet

Sponsor: Al-Mustansiriyah University | Conditions: Diabetic Maculopathy | Phase 4 | Status: RECRUITING